Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Cash from Investing Activities: 2012-2024

Historic Cash from Investing Activities for Tvardi Therapeutics (TVRD) over the last 13 years, with Dec 2024 value amounting to $48.7 million.

  • Tvardi Therapeutics' Cash from Investing Activities fell 60.44% to $8.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$36.5 million, marking a year-over-year decrease of 181.08%. This contributed to the annual value of $48.7 million for FY2024, which is 12.15% up from last year.
  • Tvardi Therapeutics' Cash from Investing Activities amounted to $48.7 million in FY2024, which was up 12.15% from $43.5 million recorded in FY2023.
  • Tvardi Therapeutics' Cash from Investing Activities' 5-year high stood at $128.7 million during FY2022, with a 5-year trough of -$20.3 million in FY2020.
  • Its 3-year average for Cash from Investing Activities is $73.6 million, with a median of $48.7 million in 2024.
  • In the last 5 years, Tvardi Therapeutics' Cash from Investing Activities soared by 2,809.05% in 2022 and then crashed by 66.23% in 2023.
  • Over the past 5 years, Tvardi Therapeutics' Cash from Investing Activities (Yearly) stood at -$20.3 million in 2020, then spiked by 76.57% to -$4.8 million in 2021, then soared by 2,809.05% to $128.7 million in 2022, then tumbled by 66.23% to $43.5 million in 2023, then grew by 12.15% to $48.7 million in 2024.